MAIA Biotechnology MAIA
NYSE MAIA
$1.13 +0.01 (+1.33%)
As of: Oct 21, 2026 · 3:59 PM EDT

MAIA Biotechnology (MAIA) Share-based Compensation (2021 - 2026)

Updated

MAIA Biotechnology's Share-based Compensation was $723,915 in Q2 2026, down 9.8% from $802,484 a year earlier but up 11.4% from the prior quarter.

Analysis

MAIA Biotechnology (MAIA) Share-based Compensation (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, MAIA Biotechnology's Share-based Compensation was $2.83 million through Jun 30, 2026, up 21.9% year-over-year; for FY2025, it came in at $2.63 million, up 37.6% from FY2024.

  • Share-based Compensation shows a four-year compound annual growth rate of -0.8% (FY2021 to FY2025).
  • In earlier years, Share-based Compensation was $1.91 million in FY2024 (-38.1%), $3.09 million in FY2023 (+33.2%), $2.32 million in FY2022 (-14.8%) and $2.72 million in FY2021.
  • Quarterly Share-based Compensation has moved between $349,965 (Q1 2024) and $1.36 million (Q4 2023) over five years.
  • Compared with a year earlier, Share-based Compensation was higher in five of the last eight quarters, with growth averaging 19.4%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q4 2023 (growth of 178.6%); the worst was Q4 2024 (a decline of 49.1%).
  • Per Business Quant data, MAIA's Share-based Compensation in the three quarters before Q2 2026 was $650,024 (Q1 2026), $810,796 (Q4 2025) and $646,900 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 166.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 249.00 Mn
10 MAIA Biotechnology 69.31 Mn -12.25 Mn - 723,915.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 723,915.00
Mar 31, 2026 650,024.00
Dec 31, 2025 810,796.00
Sep 30, 2025 646,900.00
Jun 30, 2025 802,484.00
Mar 31, 2025 371,472.00
Dec 31, 2024 693,443.00
Sep 30, 2024 455,388.00
Jun 30, 2024 413,948.00
Mar 31, 2024 349,965.00
Dec 31, 2023 1.36 Mn
Sep 30, 2023 570,916.00
Jun 30, 2023 618,932.00
Mar 31, 2023 537,522.00
Dec 31, 2022 488,891.00
Sep 30, 2022 532,438.00
Jun 30, 2022 584,768.00
Mar 31, 2022 713,330.00
Dec 31, 2021 614,025.00
Sep 30, 2021 778,544.00
API Access

MAIA Biotechnology Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MAIA&period=max&api_key=YOUR_API_KEY